Topotecan + paclitaxel: promising response, tolerability in advanced NSCLC
KeywordsLung Cancer Survival Rate Paclitaxel Partial Response Multicentre Trial
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
© Adis International Ltd 2006